Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Shares Outstanding (2016 - 2025)

Nephros (NEPH) has 15 years of Shares Outstanding data on record, last reported at $10.6 million in Q3 2025.

  • For Q3 2025, Shares Outstanding rose 0.78% year-over-year to $10.6 million; the TTM value through Sep 2025 reached $10.6 million, up 0.78%, while the annual FY2024 figure was $10.5 million, 0.41% changed from the prior year.
  • Shares Outstanding reached $10.6 million in Q3 2025 per NEPH's latest filing, roughly flat from $10.6 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $10.6 million in Q3 2025 and bottomed at $9.9 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $10.4 million, with a median of $10.3 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding: grew 12.75% in 2021, then decreased 0.06% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $10.2 million in 2021, then increased by 0.97% to $10.3 million in 2022, then grew by 1.98% to $10.5 million in 2023, then rose by 0.41% to $10.5 million in 2024, then increased by 0.78% to $10.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $10.6 million in Q3 2025, $10.6 million in Q2 2025, and $10.6 million in Q1 2025.